169 related articles for article (PubMed ID: 31943331)
21. Primary de-differentiated, trans-differentiated and undifferentiated melanomas: overview of the clinicopathological, immunohistochemical and molecular spectrum.
Ferreira I; Arends MJ; van der Weyden L; Adams DJ; Brenn T
Histopathology; 2022 Jan; 80(1):135-149. PubMed ID: 34958502
[TBL] [Abstract][Full Text] [Related]
22. PRAME immunohistochemistry in soft tissue tumors and mimics: a study of 350 cases highlighting its imperfect specificity but potentially useful diagnostic applications.
Cammareri C; Beltzung F; Michal M; Vanhersecke L; Coindre JM; Velasco V; Le Loarer F; Vergier B; Perret R
Virchows Arch; 2023 Aug; 483(2):145-156. PubMed ID: 37477762
[TBL] [Abstract][Full Text] [Related]
23. Comprehensive molecular profile of primary cutaneous epithelioid rhabdomyosarcoma: A tumor genomically and molecularly related to malignant melanoma.
Shafi S; Shah M; Jones D; Beane JD; Oghumu S; Iwenofu OH
Genes Chromosomes Cancer; 2023 Nov; 62(11):678-684. PubMed ID: 37357966
[TBL] [Abstract][Full Text] [Related]
24. Atypical Fibroxanthoma Demonstrating HMB45+ Staining.
Sahni VN; Sahni DR; Cassarino DS
Am J Dermatopathol; 2021 Dec; 43(12):e218-e221. PubMed ID: 34132658
[TBL] [Abstract][Full Text] [Related]
25. CD10, p63 and CD99 expression in the differential diagnosis of atypical fibroxanthoma, spindle cell squamous cell carcinoma and desmoplastic melanoma.
Kanner WA; Brill LB; Patterson JW; Wick MR
J Cutan Pathol; 2010 Jul; 37(7):744-50. PubMed ID: 20184665
[TBL] [Abstract][Full Text] [Related]
26. Microphthalmia transcription factor in the immunohistochemical diagnosis of metastatic melanoma: comparison with four other melanoma markers.
Miettinen M; Fernandez M; Franssila K; Gatalica Z; Lasota J; Sarlomo-Rikala M
Am J Surg Pathol; 2001 Feb; 25(2):205-11. PubMed ID: 11176069
[TBL] [Abstract][Full Text] [Related]
27. Metastatic Sarcomatoid Lung Cancer: A Rare Cutaneous Spindle Cell Neoplasm.
Yu J; Plaza JA; Schieke SM
Am J Dermatopathol; 2016 Mar; 38(3):e36-9. PubMed ID: 26894781
[TBL] [Abstract][Full Text] [Related]
28. LN2, CD10, and Ezrin Do Not Distinguish Between Atypical Fibroxanthoma and Undifferentiated Pleomorphic Sarcoma or Predict Clinical Outcome.
Hanlon A; Stasko T; Christiansen D; Cyrus N; Galan A
Dermatol Surg; 2017 Mar; 43(3):431-436. PubMed ID: 28079637
[TBL] [Abstract][Full Text] [Related]
29. SOX10: a useful marker for identifying metastatic melanoma in sentinel lymph nodes.
Willis BC; Johnson G; Wang J; Cohen C
Appl Immunohistochem Mol Morphol; 2015 Feb; 23(2):109-12. PubMed ID: 25356946
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic dilemma: late presentation of amelanotic BRAF-negative metastatic malignant melanoma resembling clear cell sarcoma: a case report.
Wagner BP; Epperla N; Medina-Flores R
Diagn Pathol; 2013 Nov; 8():192. PubMed ID: 24274261
[TBL] [Abstract][Full Text] [Related]
31. Dedifferentiated and Undifferentiated Melanomas: Report of 35 New Cases With Literature Review and Proposal of Diagnostic Criteria.
Agaimy A; Stoehr R; Hornung A; Popp J; Erdmann M; Heinzerling L; Hartmann A
Am J Surg Pathol; 2021 Feb; 45(2):240-254. PubMed ID: 33428337
[TBL] [Abstract][Full Text] [Related]
32. Cutaneous clear cell sarcoma: report of three cases of a potentially underestimated mimicker of spindle cell melanoma.
Falconieri G; Bacchi CE; Luzar B
Am J Dermatopathol; 2012 Aug; 34(6):619-25. PubMed ID: 22421295
[TBL] [Abstract][Full Text] [Related]
33. Expression of SATB2 in primary cutaneous sarcomatoid neoplasms: a potential diagnostic pitfall.
Szczepanski JM; Siddiqui J; Patel RM; Harms PW; Hrycaj SM; Chan MP
Pathology; 2023 Apr; 55(3):350-354. PubMed ID: 36732203
[TBL] [Abstract][Full Text] [Related]
34. High expression of TRF2, SOX10, and CD10 in circulating tumor microemboli detected in metastatic melanoma patients. A potential impact for the assessment of disease aggressiveness.
Long E; Ilie M; Bence C; Butori C; Selva E; Lalvée S; Bonnetaud C; Poissonnet G; Lacour JP; Bahadoran P; Brest P; Gilson E; Ballotti R; Hofman V; Hofman P
Cancer Med; 2016 Jun; 5(6):1022-30. PubMed ID: 26945789
[TBL] [Abstract][Full Text] [Related]
35. Sarcoma-like tumor of head and neck skin.
Nonaka D; Bishop PW
Am J Surg Pathol; 2014 Jul; 38(7):956-65. PubMed ID: 24705313
[TBL] [Abstract][Full Text] [Related]
36. The many faces of Atypical fibroxanthoma.
Agaimy A
Semin Diagn Pathol; 2023 Jul; 40(4):306-312. PubMed ID: 37438163
[TBL] [Abstract][Full Text] [Related]
37. Detection of Occult Invasion in Melanoma In Situ.
Bax MJ; Johnson TM; Harms PW; Schwartz JL; Zhao L; Fullen DR; Chan MP
JAMA Dermatol; 2016 Nov; 152(11):1201-1208. PubMed ID: 27533878
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical analysis of benign and malignant melanocytic lesions of the conjunctiva using double-staining.
Soon AK; Brownstein S; Tang T; Saleh S; Jiang K; Levac J; Blanco P; Farmer J
Can J Ophthalmol; 2019 Dec; 54(6):699-707. PubMed ID: 31836103
[TBL] [Abstract][Full Text] [Related]
39. Undifferentiated Sarcoma as Intermediate Step in Rhabdomyosarcomatous Transformation of a Metastatic Malignant Melanoma Resistant to Anti-BRAF Therapy: A Phenomenon Associated With Significant Diagnostic and Therapeutic Pitfalls.
Tran TAN
Int J Surg Pathol; 2019 Sep; 27(6):669-677. PubMed ID: 30942107
[TBL] [Abstract][Full Text] [Related]
40. Sarcomatoid Carcinoma With Quasi-Complete Loss of Cytokeratin Expression or Keratin-Positive Atypical Fibroxanthoma.
Roy SF; Lafaille P; Désy D
Int J Surg Pathol; 2019 Aug; 27(5):518-520. PubMed ID: 30760056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]